Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic

Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month SEOUL, South Korea, April 12, 2021 /PRNewswire/ — Seegene Inc. (KQ 096530), a biotechnology company specializing in molecular diagnostics, announced today that it has secured an…

About the Author

has written 41816 stories on this site.

Copyright © 2010 Business and Corporate News.